Tarsus Pharmaceuticals (TARS) Work In Process (2023 - 2026)

Tarsus Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Work In Process rose 113.61% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 113.61% YoY), while the FY2025 annual figure was $1.4 million, up 129.64% from the prior year.
• Work In Process for Q1 2026 stood at $1.6 million, up from $1.4 million in the prior quarter.
• The five-year high for Work In Process was $1.6 million in Q1 2026, with the low at $392000.0 in Q4 2023.
• The 4-year median for Work In Process is $1.1 million (2024), against an average of $1.1 million.
• Peak annual rise in Work In Process reached 129.64% in 2025, while the deepest fall reached 37.12% in 2025.
• Tarsus Pharmaceuticals' Work In Process stood at $392000.0 in 2023, then surged by 56.63% to $614000.0 in 2024, then soared by 129.64% to $1.4 million in 2025, then rose by 15.74% to $1.6 million in 2026.
• Business Quant data shows TARS's Work In Process at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.0 million in Q3 2025.